At a glance
| Chemical family | Paraben — methyl ester of 4-hydroxybenzoic acid; phenolic preservative with weak estrogenic activity. Paraben family includes methyl, ethyl, propyl, butyl, isopropyl, isobutyl variants — toxicokinetics and endocrine potency vary across the family |
| CAS number | 99-76-3 (also EC 202-785-7); E218 in EU food-additive labeling |
| Classification | Not formally evaluated by IARC; EU SCCS Final Opinion (December 2023) — safe as cosmetic preservative at concentrations up to 0.4% (individual) or 0.8% (combined with ethylparaben); EU Cosmetics Regulation 1223/2009 Annex V entry 12 permits methylparaben at these levels; CIR Amended Safety Assessment of Parabens — supports current use levels; US FDA — methylparaben is GRAS under cosmetic regulation framework |
| Where you encounter it | Lotions, creams, sunscreens (leave-on — highest residence-time exposure); shampoos, conditioners, body wash (rinse-off — lower per-application); deodorants and antiperspirants; cosmetics including foundation, mascara, lipstick; some food products (E218 in EU labeling); pharmaceutical formulations including some topical medications |
| Sleep micro environment relevance | Indirect but real — leave-on products containing methylparaben transfer to pillowcases, sheets, and clothing via sweat and direct skin contact over the sleep window. Bedding accumulates measurable cosmetic residue between launderings. The exposure event happens at application time; the bedroom is where transfer continues into the post-application hours |
| Activated carbon capture | Limited applicability for VOC-phase capture. Parabens are primarily a dermal absorption and product-residue contact exposure pathway, not vapor-phase. Activated carbon as designed for VOC removal is not the relevant capture technology; the primary residential intervention is product-choice level. Inferred from established cosmetic-ingredient exposure pathways; parabens-specific air capture is not the relevant technology question |
What it is
Methylparaben — CAS 99-76-3, chemical name methyl 4-hydroxybenzoate — is the methyl ester of 4-hydroxybenzoic acid (parahydroxybenzoic acid), a small phenolic compound widely distributed in plants (it is naturally present in blueberries, strawberries, and several other foods). The synthetic version, made by esterification of 4-hydroxybenzoic acid with methanol, has been in cosmetic commercial use since the 1920s, making it one of the longest-deployed cosmetic preservatives in the industry. The mechanism of antimicrobial action involves disruption of bacterial and fungal cell membrane function; methylparaben is effective against a broad spectrum of organisms including molds and yeasts, which is what makes it well-suited for water-based formulations that would otherwise grow microbial contamination during shelf life and use.
The paraben family includes methylparaben (methyl ester, the shortest chain), ethylparaben (ethyl ester), propylparaben (propyl ester), butylparaben (butyl ester), isopropylparaben, and isobutylparaben. The structural difference across the family is the alcohol used in the ester. Toxicokinetic and endocrine-potency differences across the family scale with chain length: the shorter-chain parabens (methyl, ethyl) show weaker estrogenic activity in vitro and are absorbed and metabolized more efficiently; the longer-chain parabens show progressively stronger endocrine activity in vitro and slower metabolism, which is the regulatory rationale for the EU's tighter restrictions on the longer-chain forms.
Where you encounter it
From leave-on personal care products
Lotions, creams, sunscreens, deodorants, and antiperspirants are the highest-residence-time exposure category. Once applied to skin, the leave-on product stays in contact with the body for the rest of the day, with continuing dermal absorption and transfer to clothing and (in evening application) bedding. Janjua and colleagues 2007 in Environmental Health Perspectives measured systemic absorption of methylparaben following whole-body topical application in human volunteers, documenting urinary excretion of the metabolite over the following 24 hours. Peer-reviewed
From rinse-off products
Shampoos, conditioners, body wash, and other rinse-off products contain methylparaben as a standard preservative but contribute less per-application exposure because most of the applied product is washed off within minutes. The residual fraction left on skin still produces measurable absorption, but the dose is substantially lower than from comparable-concentration leave-on products.
From cosmetics
Foundation, concealer, mascara, eyeliner, lipstick, and many other cosmetic categories use methylparaben as a preservative. The application areas (face skin, eyelashes, lips) include skin sites with relatively high permeability, particularly the periocular area for mascara and eyeliner. Cumulative daily makeup application accumulates skin contact across multiple product categories simultaneously.
From food and pharmaceutical sources
Methylparaben is approved as a food additive in the EU under the designation E218 and in the US for limited applications. Some pharmaceutical formulations (oral suspensions, topical medications) contain methylparaben as a preservative. The total dietary and pharmaceutical contribution is generally smaller than the cosmetic contribution for most US adults but is documented in biomonitoring data.
From biomonitoring data — population-scale exposure
CDC NHANES paraben biomonitoring detects methylparaben metabolites in essentially all US adults sampled. Regulatory — population-scale biomonitoring The detection rate reflects the ubiquity of cosmetic methylparaben use across the population rather than any single dominant exposure source. Higher concentrations are seen in women than men on average, consistent with higher cosmetic-product use.
What the research says
The Darbre 2004 finding and the modern controversy
Darbre, Aljarrah, Miller, Coldham, Sauer and Pope 2004 in Journal of Applied Toxicology measured paraben concentrations in 20 human breast tumor samples, detecting intact parabens (predominantly methylparaben) at mean concentrations around 20 ng/g tissue. Peer-reviewed The finding launched the modern paraben controversy and the consumer-led shift toward paraben-free product marketing. The 2004 study did not establish causality — paraben presence in tumor tissue is consistent with widespread paraben exposure and tissue distribution rather than a causal mechanism — but the finding generated substantial subsequent research and regulatory attention. Charles and Darbre 2013 extended the work, demonstrating that paraben combinations at concentrations measured in breast tissue can increase MCF-7 cancer cell proliferation in vitro. Peer-reviewed
Endocrine activity — the in vitro and animal literature
Routledge, Parker, Odum, Ashby and Sumpter 1998 in Toxicology and Applied Pharmacology demonstrated estrogenic activity of parabens in vitro and in vivo, with potency increasing through the paraben family (methyl < ethyl < propyl < butyl). Peer-reviewed The methylparaben estrogenic activity is approximately four orders of magnitude (10,000×) weaker than 17β-estradiol in standard in vitro assays. The activity is measurable; the question of clinical significance at typical residential cosmetic exposure concentrations remains the central regulatory uncertainty.
Pharmacokinetic and biomonitoring evidence
Methylparaben absorbed through skin or by ingestion is rapidly hydrolyzed in plasma and tissues to 4-hydroxybenzoic acid by carboxylesterases, and the metabolites are excreted in urine within hours to a day. The short biological half-life means current biomarker concentrations reflect recent exposure rather than long-term cumulative burden. Janjua and colleagues 2007 documented the urinary kinetics following topical whole-body application. Peer-reviewed CDC NHANES biomonitoring provides the population-scale exposure picture. Regulatory
EU SCCS 2023 Final Opinion — the current authoritative regulatory assessment
The EU Scientific Committee on Consumer Safety Final Opinion on Methylparaben (December 2023) concluded that methylparaben is safe as a cosmetic preservative at concentrations up to 0.4% (as acid) individually, or up to 0.8% combined with ethylparaben. Regulatory The opinion specifically considered the endocrine-activity literature and aggregate exposure modeling. EU Cosmetics Regulation No. 1223/2009 Annex V entry 12 implements these limits. Longer-chain parabens have been restricted more tightly: propyl and butyl parabens limited to 0.14%, with isopropyl and isobutyl parabens banned in EU cosmetics since 2014.
CIR safety assessment — the industry-funded review
The Cosmetic Ingredient Review Amended Safety Assessment of Parabens conducted the US industry-funded systematic safety review and concluded the current use levels of methylparaben are safe. Industry investigation CIR is the formal industry review body and produces structured assessments with documented methodology, but is funded by the personal care industry; the assessment is best evaluated alongside the independent regulatory SCCS opinion rather than as a primary source.
Broader paraben safety reviews
Soni, Carabin and Burdock 2005 in Food and Chemical Toxicology reviewed methylparaben safety with attention to dietary and cosmetic exposure. Peer-reviewed Boberg, Taxvig, Christiansen and Hass 2010 in Reproductive Toxicology reviewed the paraben endocrine-disruption literature with attention to reproductive and developmental endpoints. Peer-reviewed
What helps reduce exposure
Read ingredient labels and choose paraben-free formulations where the replacement preservative is identified. "Paraben-free" without specifying what preservative system was used substitutes one unknown for another. Phenoxyethanol, ethylhexylglycerin, sodium benzoate, benzyl alcohol, and potassium sorbate are common replacements with their own evidence profiles. The transparency level of the brand matters more than the marketing claim.
Prioritize leave-on products for paraben-free choices. Lotions, sunscreens, deodorants, and similar leave-on categories produce the highest residence-time exposure. Rinse-off products contribute less per application. If you're choosing where to spend the marginal effort, the leave-on category is where the per-product change matters most.
For children specifically, the per-body-weight exposure argument is stronger. Higher skin-surface-to-body-mass ratio and higher skin permeability in young children produce higher relative paraben exposure per application than in adults. Pediatric-specific product selection for routine leave-on use is reasonable.
Wash bedding regularly. Cosmetic residue including parabens accumulates on pillowcases, sheets, and clothing between launderings. Weekly hot-water washing of bedding reduces the cumulative bedding load.
Consider total cosmetic-product load rather than single-ingredient avoidance. Households using many separate leave-on products receive cumulative paraben exposure across the products. Simplifying the routine reduces the total exposure regardless of which specific preservative each product uses.
What does NOT help
- Generic "natural" or "clean beauty" labels without verifiable ingredient lists. These terms are unregulated. Brands using them set their own internal standards. Independent ingredient disclosure or third-party certification (MADE SAFE, EWG Verified, COSMOS for organic) is more reliable than self-declared marketing claims.
- Stating "parabens cause breast cancer" as established science. The Darbre 2004 finding documented paraben presence in tumor tissue but did not establish causality. The subsequent literature has not demonstrated a causal link in human populations. Overclaim on either side of this debate is unhelpful.
- Assuming all paraben replacements are safer. The regrettable-substitution pattern documented for bisphenols (BPA → BPS → BPF) also applies to personal care preservatives. Each replacement chemistry deserves its own assessment.
- Avoiding all preservatives entirely. Water-containing cosmetic formulations without preservatives can grow microbial contamination that produces its own health risks (eye infections from contaminated mascara, skin infections from contaminated lotions). The preservation question is which system, not whether to have one.
Open research questions
- Cumulative exposure across the paraben family vs single-compound effects — the EU SCCS 2023 opinion modeled aggregate exposure, but the longitudinal dose-response for combined cosmetic-and-dietary paraben intake across decades has not been precisely characterized. Speculation re: long-term aggregate effect
- Bedroom-specific exposure pathways — pillowcase and bedding paraben deposition has not been quantitatively studied at population scale. The Janjua kinetic studies document skin-to-systemic absorption; the skin-to-bedding-to-skin recirculation has not been characterized. Inferred from general cosmetic transfer behavior; paraben-specific bedding studies are sparse
- Endocrine effects at very low chronic doses — the in vitro and animal evidence is established; the human dose-response below regulatory limits remains an active area, particularly during developmental windows. Speculation
- Replacement preservative safety profiles — as paraben-free formulations proliferate, the cumulative-population exposure to phenoxyethanol, sodium benzoate, and other replacements is increasing without parallel safety scrutiny. Speculation
Citations
- Scientific Committee on Consumer Safety (2023). Opinion on Methylparaben (CAS No. 99-76-3, EC No. 202-785-7) — Final. European Commission, Health and Food Safety Directorate-General, SCCS/1652/23. health.ec.europa.eu Regulatory — current authoritative cosmetic safety assessment
- European Commission. Cosmetics Regulation (EC) No. 1223/2009 — Annex V (list of preservatives allowed in cosmetic products), entry 12 (methylparaben and ethylparaben at 0.4%/0.8% combined). health.ec.europa.eu/cosmetic-products Regulatory
- Cosmetic Ingredient Review. Amended Safety Assessment of Parabens as Used in Cosmetics. cir-safety.org Industry investigation — formal industry safety review
- Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS (2004). Concentrations of parabens in human breast tumours. Journal of Applied Toxicology, 24(1):5-13. DOI 10.1002/jat.958 Peer-reviewed — foundational paraben breast tissue measurement
- Charles AK, Darbre PD (2013). Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of MCF-7 human breast cancer cells. Journal of Applied Toxicology, 33(5):390-398. DOI 10.1002/jat.2850 Peer-reviewed
- Routledge EJ, Parker J, Odum J, Ashby J, Sumpter JP (1998). Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicology and Applied Pharmacology, 153(1):12-19. DOI 10.1006/taap.1998.8544 Peer-reviewed — foundational paraben estrogenicity demonstration
- Janjua NR, Mortensen GK, Andersson AM, Kongshoj B, Skakkebæk NE, Wulf HC (2007). Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environmental Health Perspectives, 115(4):617-624. DOI 10.1289/ehp.10046 Peer-reviewed
- Soni MG, Carabin IG, Burdock GA (2005). Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food and Chemical Toxicology, 43(7):985-1015. DOI 10.1016/j.fct.2005.05.011 Peer-reviewed
- Boberg J, Taxvig C, Christiansen S, Hass U (2010). Possible endocrine disrupting effects of parabens and their metabolites. Reproductive Toxicology, 30(2):301-312. DOI 10.1016/j.reprotox.2010.06.012 Peer-reviewed
- US Centers for Disease Control and Prevention. National Report on Human Exposure to Environmental Chemicals — NHANES paraben biomonitoring. cdc.gov/exposurereport Regulatory — population-scale biomonitoring
Frequently asked questions
Is methylparaben safe?
The EU Scientific Committee on Consumer Safety's Final Opinion (December 2023) concluded that methylparaben is safe as a cosmetic preservative at concentrations up to 0.4% (as acid) individually, or up to 0.8% combined with ethylparaben. This is the most recent and most rigorous regulatory safety assessment specifically addressing endocrine-disruption concerns. The US FDA continues to permit methylparaben in cosmetics under the broader cosmetic regulation framework. Methylparaben is the shortest-chain paraben and shows substantially weaker endocrine activity than the longer-chain parabens (propyl, butyl, isopropyl, isobutyl) that EU has restricted further.
Why are parabens in skincare products?
Parabens are broad-spectrum antimicrobial preservatives that prevent bacterial and fungal contamination of cosmetic and personal care products during their shelf life and use. Without effective preservatives, water-containing formulations can grow microbial contamination that produces its own health risks — eye infections from contaminated mascara, skin infections from contaminated lotions. Methylparaben has been used in cosmetics since the 1920s and is one of the longest-studied preservative systems in the industry. The trade-off is real: preservation systems all carry some chemistry burden; the question is which preservative system has the most favorable risk-benefit profile.
Do parabens cause breast cancer?
The scientific evidence is contested. Darbre and colleagues' 2004 finding of intact parabens in human breast tumor tissue launched the modern paraben controversy and drove the shift toward paraben-free product marketing. The subsequent epidemiological literature has not established a causal link between paraben exposure and breast cancer incidence. The EU SCCS 2023 final opinion concluded methylparaben is safe at the 0.4% concentration limit even accounting for the endocrine-activity literature. Stating the parabens-cause-breast-cancer claim as scientifically established is overclaim; stating it as scientifically refuted is also overclaim. The honest framing: the literature documents endocrine activity in vitro and limited human breast tissue accumulation; causal claims for cancer outcomes are not supported by current human evidence.
What does paraben-free mean?
Paraben-free labels indicate the product does not contain methylparaben, ethylparaben, propylparaben, butylparaben, or other ester-of-parahydroxybenzoic-acid preservatives. Paraben-free does not mean preservative-free — the formulator has used an alternative preservation system, typically phenoxyethanol, ethylhexylglycerin, sodium benzoate, benzyl alcohol, or potassium sorbate. Each replacement preservative has its own safety profile; some carry their own concerns. Paraben-free is a meaningful product specification, but the alternative chemistry deserves equal scrutiny rather than assumed safety.
Are paraben alternatives any safer?
Mixed. The replacement preservative chemistry varies, and the regrettable-substitution pattern documented for bisphenols (BPA → BPS → BPF) and PFAS chemistry also applies to personal care preservatives. Phenoxyethanol is generally considered well-characterized and acceptable at the regulatory concentration limits. Some plant-derived natural preservatives have allergy and sensitization concerns of their own. The honest framing: paraben-free is not automatically safer; verify what preservative system is in use and assess that chemistry on its own merits.
How long do parabens stay in the body?
Parabens have short biological half-lives — most absorbed methylparaben is hydrolyzed to 4-hydroxybenzoic acid and conjugated metabolites in the liver and excreted in urine within hours to a day. The Janjua and colleagues 2007 pharmacokinetic study documented rapid urinary excretion of paraben metabolites following topical application. The short half-life means current biomarker levels reflect recent exposure rather than long-term cumulative burden. The flip side: stopping exposure produces relatively rapid reduction in body paraben levels, unlike the decades-long persistence of lead or cadmium.
What's the difference between methylparaben and propylparaben?
Both are esters of 4-hydroxybenzoic acid, differing in the alcohol used in the ester. Methylparaben uses methanol (shortest chain); propylparaben uses 1-propanol (intermediate chain). The shorter-chain parabens (methyl, ethyl) show weaker estrogenic activity in vitro and are absorbed and metabolized more efficiently. The longer-chain parabens (propyl, butyl, isopropyl, isobutyl) show progressively stronger endocrine activity and were restricted more tightly by the EU SCCS — propyl and butyl are limited to 0.14% in EU cosmetics; isopropyl and isobutyl have been banned in EU cosmetics since 2014. The methylparaben 0.4% limit is the most permissive of the regulatory levels because the chemistry is the least concerning of the paraben family.
Related compounds
Embr Sleep is a sleep environment company researching the chemistry of the bedroom. See the methodology page for how this Atlas tags claims by evidence strength. For broader context on personal care chemistry and bedroom transfer, see non-toxic bedroom.
Last reviewed 2026-05-25. If you find a factual error, contact us.